Acetaminophen Tablet, Extended Release
Product Images NDC 62207-183

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Acetaminophen (NDC 62207-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acetaminophen 650mg Er

Acetaminophen Extended Release Tablets USP, 650 mg are available in batches of 5x3000 units. Each tablet contains Acetaminophen USP 650 mg. The details of the manufacturer's license number, batch number, manufacturing date, expiration date, NDC number and storage conditions are mentioned on the packaging. Caution is advised for repacking purposes only.*

FDA Label Image

Acetaminophen-650mg (Acetaminophen 650mg Label1)

This text is a drug label for Acetaminophen Extended-release tablets USP for minor muscle aches and pains. It contains drug facts and dosage instructions. The label is produced by Granses Nia Limited, located in Hyderabad, India.*

FDA Label Image

Acetaminophen-650mg (Acetaminophen 650mg Label2)

FDA Label Image

Acetaminophen-650mg (Acetaminophen 650mg Label3)

This is a drug label for a pain relief medication that contains Acetaminophen USP in extended-release tablets for minor muscle aches and pains, including those related to backaches, arthritis, toothaches, and menstrual cramps. It can also temporarily relieve fever. However, it should not be used with other medications containing Acetaminophen, and taking more than six caplets in a 24-hour period may cause severe liver damage. The product is manufactured in India and distributed in the USA by Granules USA, Inc. There is information about the lot number and expiration date that is not visible in the provided text.*

FDA Label Image

Acetaminophen-650mg (Acetaminophen 650mg Label4)

This is a drug called Arthritis Pain which is designed to temporarily relieve minor arthritis pain. It is an extended-release tablet containing 650mg of acetaminophen, a pain reliever, and fever reducer. The drug comes in capsule-shaped bi-layer caplets and is intended for use only by adults. The packaging contains warnings against taking more than six caplets within 24 hours due to the risk of severe liver damage. Additionally, it is not intended to be used with other medications containing acetaminophen. The product is manufactured by Granules India Limited in Hyderabad, India, and distributed by Granules USA, Inc. in Parsippany, NJ.*

FDA Label Image

Acetaminophen 650mg

This is a description of Acetaminophen Extended Release Tablets USP, 650 mg. It includes information on the contents of each tablet, batch number, number of units, manufacturing and expiration dates, NDC number, manufacturing license number, storage instructions, country of origin, caution for repackaging, and a product code.*

FDA Label Image

Acetaminophen Er 650mg Bulk Jpg

Acetaminophen Extended Release Tablets USP, 650 mg with batch number, manufacturing, and expiry dates. It includes storage and caution instructions. NDC number, net weight, and other details are mentioned. It is a digitally signed product.*

FDA Label Image

Acetaminophen Label1 Jpg

FDA Label Image

Acetaminophen Label2 Jpg

This is a packaging label for 650mg Acetaminophen extended-release tablets that provide pain relief and reduce fever for up to 8 hours. The tablets are produced by Granules India Limited and distributed by Granules USA, Inc. The label includes the manufacturer and distributor address details, ingredients available, and precautions about not using it with other medications that contain acetaminophen. The rest of the information is not readable due to errors and missing characters.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.